市場調査レポート
商品コード
990218

ゲノミクスの世界市場 (~2025年):製品&サービス (システム&ソフトウェア・消耗品・サービス)・技術 (シーケンス・PCR)・用途 (創薬&開発・診断・農業)・エンドユーザー (病院&クリニック・研究センター)・地域別

Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) - Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 192 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
ゲノミクスの世界市場 (~2025年):製品&サービス (システム&ソフトウェア・消耗品・サービス)・技術 (シーケンス・PCR)・用途 (創薬&開発・診断・農業)・エンドユーザー (病院&クリニック・研究センター)・地域別
出版日: 2021年02月15日
発行: MarketsandMarkets
ページ情報: 英文 192 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のゲノミクスの市場規模は予測期間中19.0%のCAGRで推移し、2020年の227億米ドルから、2025年には544億米ドルの規模に成長すると予測されています。

ゲノミクスプロジェクトをサポートする政府資金の増加、癌の発生率の増加、癌研究におけるNGSの利用の増加、ゲノミクス市場への新規事業者の参入、ゲノミクスの応用分野の成長などの要因が同市場の成長を推進しています。

用途別で見ると、創薬・開発の部門が2019年に最大のシェアを示しています。癌や遺伝性疾患などの疾患研究の増加、シーケンシングコストの減少などの要因が同部門の成長を牽引しています。また、地域別では、市場シェアでは北米地域が最大の規模を示し、成長率では、アジア太平洋地域が最大の成長を示すと予測されています。

当レポートでは、世界のゲノミクスの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術動向、市場規模の推移・予測、製品&サービス・技術・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 市場機会
    • 課題
    • 動向
  • 技術分析
  • バリューチェーン分析
  • 規制分析
  • エコシステム分析

第6章 市場分析・予測:製品・サービス別

  • 消耗品
  • システム・ソフトウェア
  • サービス

第7章 市場分析・予測:技術別

  • シーケンシング
  • PCR
  • 核酸抽出・精製
  • マイクロアレイ
  • その他

第8章 市場分析・予測:用途別

  • 創薬・開発
  • 診断
  • 農業・動物研究
  • その他

第9章 市場分析・予測:エンドユーザー別

  • 病院・クリニック
  • 研究センター・学術機関・政府機関
  • 製薬・バイオテクノロジー企業
  • その他

第10章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第11章 競合情勢

  • 市場シェア分析
  • 市場評価の枠組み
  • 競合ベンチマーキング
  • 競合シナリオ
  • 企業評価マトリックス

第12章 企業プロファイル

  • 主要企業
    • ILLUMINA, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • QIAGEN N.V.
    • AGILENT TECHNOLOGIES
    • F. HOFFMANN-LA ROCHE, LTD.
    • BIO-RAD LABORATORIES, INC.
    • EUROFINS SCIENTIFIC
    • OXFORD NANOPORE TECHNOLOGIES
    • BGI
    • DANAHER CORPORATION
    • EPPENDORF AG
    • MERCK KGAA
    • NEW ENGLAND BIOLABS
    • PROMEGA CORPORATION
    • CREATIVE BIOGENE
    • スタートアップSME

第13章 付録

目次
Product Code: BT 2209

The global genomics market is projected to reach USD 54.4 billion by 2025 from USD 22.7 billion in 2020, at a CAGR of 19.0% during the forecast period. The major factors driving the growth of this market include the increasing government funding to support genomics projects, the growing incidence of cancer and increasing applications of NGS in cancer research, the entry of new players and start-ups in the genomics market, and the growing application areas of genomics.

"By product segment, the consumables accounted for the fastest growing segment of the genomics market"

Based on product & service, the genomics market is segmented into consumables, systems & software, and services. In 2019, consumables accounted for the fastest growing segment of the genomics market during the forecast period. Consumables are used in large numbers in genomic systems, and their use will continue to increase with the growing number of genomic tests performed across the globe. This is a key factor driving the market growth.

"By application, the drug discovery and development segment accounted for the largest share of the genomics market"

Based on application, the genomics market is segmented into drug discovery and development, diagnostics, agriculture and animal research, and other applications. Drug discovery and development accounted for the largest application segment in the genomics market in 2019. The large share of this segment can be attributed to the increasing research on diseases such as cancer and genetic disorders and the decreasing cost of sequencing.

"Asia Pacific: The fastest-growing region in the genomics market."

The genomics market in the Asia Pacific is projected to register the highest growth during the forecast period, mainly due to favorable government support for genomics projects, increasing awareness about newer genomics technologies such as NGS, and expansions of key players to strengthen their presence in the APAC region.

"North America: the largest share of the genomics market"

North America accounted for the largest share of the genomics market. Increasing government initiatives for promoting precision medicine, adoption of several strategies by key players to provide efficient genomics solutions in this region, and the presence of prominent players are the major drivers of the North American market.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 80%, Demand Side-20%
  • By Designation- CXOs - 20%, Executives - 25%, Mangers - 55%
  • By Region- North America - 30%, Europe - 20%, APAC - 40%, RoW- 10%

The genomics market is dominated by a few globally established players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche (Switzerland), BGI (China), Eurofins Scientific (Germany), Oxford Nanopore Technologies (UK), Danaher Corporation (US), Merck KGaA (Germany), Eppendorf AG (Germany), Promega Corporation (US), Creative Biogene (US), New England Biolabs (US), Source BioScience (UK), Bionano Genomics (US), Macrogen, Inc. (South Korea), BioDiscovery (UK), Veritas Genetics International (US), and start-up companies such as 23andMe (US), Personalis (US), Novogene Co., Ltd. (China), Helix OpCo, LLC (US), Personal Genome Diagnostics Inc. (US), Phalanx Biotech Group (US), MedGenome (US), Resilient Biotics, Inc. (US), TruGenomix Health (US), and Cradle Genomics (US).

Research Coverage:

The report segments the genomics market based on region (Asia Pacific, Europe, North America, and RoW), product & service (systems & software, consumables and services), technology (sequencing technologies, PCR, nucleic acid extraction and purification, microarrays, and other technologies), application (drug discovery and development, diagnostics, agriculture and animal research, and other applications), end user (hospitals & clinics, research centers and academic & government institutes, pharmaceutical & biotechnology companies, and other end users). The report also provides a comprehensive review of market drivers, opportunities, challenges and trends in the genomics market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the genomics market and provides them information on key market drivers, challenges, opportunities and trends.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • 2.1.3 MARKET DATA ESTIMATION AND TRIANGULATION
    • 2.1.4 DATA TRIANGULATION
    • FIGURE 1 DATA TRIANGULATION METHODOLOGY
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 2 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • FIGURE 3 GENOMICS MARKET SIZE (USD BILLION)
    • FIGURE 4 GENOMICS MARKET: FINAL CAGR PROJECTIONS (2020-2025)
    • FIGURE 5 GENOMICS MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 6 GENOMICS MARKET: SEGMENTAL ASSESSMENT
  • 2.3 INDUSTRY INSIGHTS
  • 2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 GENOMICS MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD BILLION)
    • FIGURE 8 GENOMICS MARKET SHARE, BY TECHNOLOGY, 2019
    • FIGURE 9 GENOMICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
    • FIGURE 10 GENOMICS MARKET, BY END USER, 2020-2025
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 GENOMICS MARKET OVERVIEW
    • FIGURE 12 INCREASING GOVERNMENT FUNDING TO SUPPORT GENOMICS PROJECTS TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION & COUNTRY (2019)
    • FIGURE 13 DRUG DISCOVERY AND DEVELOPMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019
  • 4.3 GENOMICS MARKET FOR SEQUENCING, BY TYPE
    • FIGURE 14 NEXT-GENERATION SEQUENCING PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 GENOMICS MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing government funding to support genomics projects
      • 5.2.1.2 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
    • TABLE 1 GLOBAL CANCER INCIDENCE, 2020 VS. 2040
      • 5.2.1.3 Entry of new players and start-ups in the genomics market
      • 5.2.1.4 Growing application areas of genomics
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Use of genomics in specialized/personalized medicine
    • 5.2.3 CHALLENGES
      • 5.2.3.1 High cost of genomic equipment
      • 5.2.3.2 Dearth of trained professionals
      • 5.2.3.3 Secure storage of large volumes of sequenced data
    • 5.2.4 TRENDS
      • 5.2.4.1 Partnerships and collaborations for technological advancements in genomics
      • 5.2.4.2 Impact of COVID-19 on the genomics market
  • 5.3 TECHNOLOGICAL ANALYSIS
    • TABLE 2 COMPARISON OF SANGER SEQUENCING AND NGS
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 16 VALUE CHAIN ANALYSIS-MAXIMUM VALUE IS ADDED DURING THE SEQUENCING AND ANALYSIS PHASE
  • 5.5 REGULATORY ANALYSIS
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • TABLE 3 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 4 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.5.2 EUROPE
    • FIGURE 17 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
      • 5.5.2.1 Asia Pacific
        • 5.5.2.1.1 China
    • TABLE 5 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • 5.6 ECOSYSTEM ANALYSIS OF THE GENOMICS MARKET
    • FIGURE 18 ECOSYSTEM ANALYSIS OF THE GENOMICS MARKET

6 GENOMICS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 6 GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
  • 6.2 CONSUMABLES
    • 6.2.1 CONSUMABLES FORM THE LARGEST PRODUCT SEGMENT OF THE GENOMICS MARKET
    • TABLE 7 GENOMICS CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 8 GENOMICS CONSUMABLES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.3 SYSTEMS & SOFTWARE
    • 6.3.1 DECLINING RATES OF GENOME SEQUENCING TO INCREASE THE DEMAND FOR GENOMICS SYSTEMS & SOFTWARE
    • TABLE 9 GENOMICS SYSTEMS & SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 10 GENOMICS SYSTEMS & SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 HIGH COST OF GENOMIC INSTRUMENTS AND THE POSSIBILITY OF INSTRUMENT OBSOLESCENCE HAVE DRIVEN END USERS TO OUTSOURCE THEIR SEQUENCING NEEDS
    • TABLE 11 GENOMICS SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 12 GENOMICS SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

7 GENOMICS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 13 GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
  • 7.2 SEQUENCING
    • 7.2.1 INCREASING APPLICATIONS OF SEQUENCING IN HUMAN GENOMICS TO DRIVE MARKET GROWTH
    • TABLE 14 GENOMICS MARKET FOR SEQUENCING, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 15 GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 16 GENOMICS MARKET FOR SEQUENCING, BY TYPE, 2018-2025 (USD MILLION)
  • 7.3 PCR
    • 7.3.1 PCR ALLOWS RESEARCHERS TO PRODUCE MILLIONS OF COPIES OF A SPECIFIC DNA SEQUENCE WITHIN HOURS
    • TABLE 17 GENOMICS MARKET FOR PCR, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 18 GENOMICS MARKET FOR PCR, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.4 NUCLEIC ACID EXTRACTION AND PURIFICATION
    • 7.4.1 ADVANCES IN NUCLEIC ACID EXTRACTION AND PURIFICATION TECHNOLOGIES ARE EXPECTED TO SUPPORT THE GROWTH OF THIS MARKET
    • TABLE 19 GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 20 GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.5 MICROARRAYS
    • 7.5.1 HIGH ADOPTION OF NGS MAY LIMIT THE GROWTH OF MICROARRAY TECHNOLOGIES IN THIS MARKET TO A CERTAIN EXTENT
    • TABLE 21 GENOMICS MARKET FOR MICROARRAYS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 22 GENOMICS MARKET FOR MICROARRAYS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.6 OTHER TECHNOLOGIES
    • TABLE 23 GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 24 GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018-2025 (USD MILLION)

8 GENOMICS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 25 GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.2 DRUG DISCOVERY AND DEVELOPMENT
    • 8.2.1 DRUG DISCOVERY AND DEVELOPMENT FORMS THE LARGEST APPLICATION SEGMENT OF THE GENOMICS MARKET
    • TABLE 26 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 27 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.3 DIAGNOSTICS
    • 8.3.1 GROWING APPLICATIONS OF GENOMICS IN THE DIAGNOSTICS FIELD TO PROPEL MARKET GROWTH
    • TABLE 28 GRANTS, BY CANCER TYPE (AS OF OCTOBER 2020)
    • TABLE 29 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 30 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 31 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  • 8.4 AGRICULTURE AND ANIMAL RESEARCH
    • 8.4.1 GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 32 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 33 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.5 OTHER APPLICATIONS
    • TABLE 34 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 35 GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)

9 GENOMICS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 36 GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.2 HOSPITALS & CLINICS
    • 9.2.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS
    • TABLE 37 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 38 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.3 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
    • 9.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF GENOMICS PRODUCTS AMONG ACADEMIC & GOVERNMENT INSTITUTES
    • TABLE 39 GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 40 GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF GENOMICS PRODUCTS & SERVICES AMONG PHARMA & BIOTECH COMPANIES
    • TABLE 41 GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 42 GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 43 GENOMICS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 44 GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2025 (USD MILLION)

10 GENOMICS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD
    • TABLE 45 GENOMICS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
    • TABLE 46 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 47 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 48 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 49 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 50 NORTH AMERICA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 US dominates the North American genomics market
    • TABLE 51 US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 52 US: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 53 US: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 54 US: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Increasing research in the field of genomics to drive market growth
    • TABLE 55 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 56 CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 57 CANADA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 58 CANADA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 59 EUROPE: GENOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 60 EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 61 EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 62 EUROPE: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 63 EUROPE: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.1 UK
      • 10.3.1.1 Availability of government funding and strategic collaborations with biotech firms to boost the market
    • TABLE 64 UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 65 UK: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 66 UK: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 67 UK: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing awareness of NGS in the country to boost the market growth in Germany
    • TABLE 68 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 69 GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 70 GERMANY: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 71 GERMANY: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing government investments in genomics to boost the growth of the French genomics market
    • TABLE 72 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 73 FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 74 FRANCE: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 75 FRANCE: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.4 ROE
    • TABLE 76 ROE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 77 ROE: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 78 ROE: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 79 ROE: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 21 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
    • TABLE 80 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 84 ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 China is expected to command the largest share of the Asia Pacific market
    • TABLE 85 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 86 CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 87 CHINA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 88 CHINA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Growing conferences and workshops on newer genomics technologies such as NGS to increase awareness and drive the market
    • TABLE 89 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 90 JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 91 JAPAN: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 92 JAPAN: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Emergence of local players & increasing adoption of genomics technologies is expected to aid the growth of the genomics market in India
    • TABLE 93 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 94 INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 95 INDIA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 96 INDIA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 97 ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 98 ROAPAC: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 99 ROAPAC: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 100 ROAPAC: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 101 ROW: GENOMICS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 102 ROW: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 103 ROW: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 104 ROW: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 105 ROW: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Expansions of key players in Latin American regions to boost the market
    • TABLE 106 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 107 LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 108 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 109 LATIN AMERICA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Increasing adoption of genetic testing in the Middle East and rising HIV & cancer incidence in Africa are driving market growth
    • TABLE 110 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION)
    • TABLE 111 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY TECHNOLOGY, 2018-2025 (USD MILLION)
    • TABLE 112 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 113 MIDDLE EAST & AFRICA: GENOMICS MARKET, BY END USER, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET SHARE ANALYSIS
    • FIGURE 22 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
  • 11.3 MARKET EVALUATION FRAMEWORK
    • TABLE 114 MARKET EVALUATION FRAMEWORK: PRODUCT & SERVICE LAUNCHES -THE MAJOR STRATEGY ADOPTED BY PLAYERS
  • 11.4 COMPETITIVE BENCHMARKING
    • 11.4.1 ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE GENOMICS MARKET
  • 11.5 COMPETITIVE SCENARIO
    • 11.5.1 KEY PRODUCT LAUNCHES
    • 11.5.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
    • 11.5.3 KEY EXPANSIONS
    • 11.5.4 KEY ACQUISITIONS
  • 11.6 COMPANY EVALUATION MATRIX
    • 11.6.1 GLOBAL GENOMICS MARKET: COMPANY EVALUATION MATRIX (OVERALL MARKET) (2019)
      • 11.6.1.1 Stars
      • 11.6.1.2 Emerging leaders
      • 11.6.1.3 Pervasive players
      • 11.6.1.4 Participants
    • FIGURE 23 GLOBAL GENOMICS MARKET: COMPANY EVALUATION MATRIX, 2019
    • 11.6.2 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2019)
      • 11.6.2.1 Progressive companies
      • 11.6.2.2 Starting blocks
      • 11.6.2.3 Dynamic companies
      • 11.6.2.4 Responsive companies
    • FIGURE 24 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)**
  • 12.1 MAJOR PLAYERS
    • 12.1.1 ILLUMINA, INC.
    • FIGURE 25 ILLUMINA, INC.: COMPANY SNAPSHOT (2019)
    • 12.1.2 THERMO FISHER SCIENTIFIC, INC.
    • FIGURE 26 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
    • 12.1.3 QIAGEN N.V.
    • FIGURE 27 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
    • 12.1.4 AGILENT TECHNOLOGIES
    • FIGURE 28 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2020)
    • 12.1.5 F. HOFFMANN-LA ROCHE, LTD.
    • FIGURE 29 F. HOFFMANN-LA ROCHE, LTD.: COMPANY SNAPSHOT (2019)
    • 12.1.6 BIO-RAD LABORATORIES, INC.
    • FIGURE 30 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
    • 12.1.7 EUROFINS SCIENTIFIC
    • FIGURE 31 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
    • 12.1.8 OXFORD NANOPORE TECHNOLOGIES
    • 12.1.9 BGI
    • 12.1.10 DANAHER CORPORATION
    • FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.1.11 EPPENDORF AG
    • FIGURE 33 EPPENDORF AG: COMPANY SNAPSHOT (2019)
    • 12.1.12 MERCK KGAA
    • FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • 12.1.13 NEW ENGLAND BIOLABS
    • 12.1.14 PROMEGA CORPORATION
    • 12.1.15 CREATIVE BIOGENE
    • 12.1.16 START-UP/SME PLAYERS
      • 12.1.16.1 Novogene Co., Ltd.
      • 12.1.16.2 Helix OpCo, LLC
      • 12.1.16.3 23andMe, Inc.
      • 12.1.16.4 Personal Genome Diagnostics Inc. (PGDx)
      • 12.1.16.5 Personalis, Inc.
  • *Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS